- Home
- IHRT vs ALDX Comparison
IHRT vs ALDX Comparison
Compare IHRT & ALDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IHRT
- ALDX
- Stock Information
- Founded
- IHRT 1974
- ALDX 2004
- Country
- IHRT United States
- ALDX United States
- Employees
- IHRT N/A
- ALDX N/A
- Industry
- IHRT Broadcasting
- ALDX Biotechnology: Pharmaceutical Preparations
- Sector
- IHRT Consumer Discretionary
- ALDX Health Care
- Exchange
- IHRT Nasdaq
- ALDX Nasdaq
- Market Cap
- IHRT 310.3M
- ALDX 304.9M
- IPO Year
- IHRT 2019
- ALDX 2014
- Fundamental
- Price
- IHRT $1.55
- ALDX $6.81
- Analyst Decision
- IHRT Buy
- ALDX Strong Buy
- Analyst Count
- IHRT 3
- ALDX 2
- Target Price
- IHRT $2.83
- ALDX $10.00
- AVG Volume (30 Days)
- IHRT 1.1M
- ALDX 612.4K
- Earning Date
- IHRT 05-08-2025
- ALDX 05-01-2025
- Dividend Yield
- IHRT N/A
- ALDX N/A
- EPS Growth
- IHRT N/A
- ALDX N/A
- EPS
- IHRT N/A
- ALDX N/A
- Revenue
- IHRT $3,854,532,000.00
- ALDX N/A
- Revenue This Year
- IHRT $1.80
- ALDX N/A
- Revenue Next Year
- IHRT $5.22
- ALDX N/A
- P/E Ratio
- IHRT N/A
- ALDX N/A
- Revenue Growth
- IHRT 2.76
- ALDX N/A
- 52 Week Low
- IHRT $0.81
- ALDX $2.71
- 52 Week High
- IHRT $2.84
- ALDX $7.20
- Technical
- Relative Strength Index (RSI)
- IHRT 34.65
- ALDX 60.42
- Support Level
- IHRT $1.48
- ALDX $4.78
- Resistance Level
- IHRT $1.95
- ALDX $7.20
- Average True Range (ATR)
- IHRT 0.21
- ALDX 0.56
- MACD
- IHRT -0.04
- ALDX 0.03
- Stochastic Oscillator
- IHRT 11.17
- ALDX 83.88
About IHRT iHeartMedia Inc.
iHeartMedia Inc is a United States-based diversified media and entertainment company. The company operates through the segments of the Multiplatform Group, the Digital Audio Group, and the Audio & Media Services Group. The company derives prime revenue from the Multiplatform Group segment which includes the company's Broadcast radio, Networks and Sponsorships, and Events businesses. The Digital Audio Group segment includes all of the company's digital businesses, including podcasting; and the Audio & Media Services Group includes Katz Media Group, a full-service media representation business, and RCS Sound Software, a provider of scheduling and broadcast software and services.
About ALDX Aldeyra Therapeutics Inc.
Aldeyra Therapeutics Inc is a biotechnology company engaged in developing and commercializing next-generation medicines to improve the lives of patients with immune-mediated diseases. The company's product candidate, reproxalap, is a first-in-class treatment in late-stage development for dry eye disease and allergic conjunctivitis. In addition, it also has additional product candidates in development for proliferative vitreoretinopathy, primary vitreoretinal lymphoma and other retinal diseases, autoimmune disease, and cancer.